Join the Menopausal Disorders group to help and get support from people like you.
Menopausal Disorders News (Page 6)
Related terms: Change of Life, Menopause, Climacteric
Risk of Hypertension Up With Use of Oral Estrogen-Only Hormone Therapy
THURSDAY, June 8, 2023 – For postmenopausal women using estrogen-only hormone therapy (HT), oral estrogen-only HT use is associated with increased risk of hypertension, according to a study...
Could a Nitroglycerin Patch Ease Hot Flashes?
TUESDAY, June 6, 2023 – A new study on using nitroglycerin patches to help women with frequent hot flashes caused by menopause has delivered mixed results. The benefits of wearing these patches — l...
One Form of Menopause Hormone Therapy Might Raise Blood Pressure
MONDAY, June 5, 2023 – Women who use estrogen to ease menopause symptoms may see their blood pressure rise — but the way they take the hormone may determine that, a large new study suggests. The s...
Fracture Risk Up With Prediabetes Before Menopause Transition
TUESDAY, May 30, 2023 – For women in midlife, prediabetes before the menopause transition (MT) is associated with increased risk of incident fracture during and after the transition, according to a...
Catching Extra Sleep on Weekends Tied to Lower Risk for Hyperuricemia
WEDNESDAY, May 24, 2023 – Weekend catch-up sleep among postmenopausal women is associated with a decreased prevalence of hyperuricemia, according to a study published online May 16 in Menopause. Soo...
FDA Approves Veozah (fezolinetant) for the Treatment of Vasomotor Symptoms Due to Menopause
TOKYO, May 13 2023 – Astellas Pharma Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Veozah (fezolinetant) 45 mg once daily for the treatment of moderate to severe v...
FDA Approves First Nonhormonal Drug, Veozah, to Ease Menopause Hot Flashes
MONDAY, May 15, 2023 – The U.S. Food and Drug Administration on Friday approved the first nonhormonal medication aimed at easing menopause hot flashes. The new pill, called Veozah (fezolinetant), is...
FDA Approves First Nonhormonal Drug to Ease Menopause Hot Flashes
SATURDAY, May 13, 2023 – The U.S. Food and Drug Administration on Friday approved the first nonhormonal medication aimed at easing menopause hot flashes. The new pill, called Veozah (fezolinetant),...
Hormone Preparations Tied to Increased Bone Mineral Density in Postmenopausal Women
THURSDAY, May 11, 2023 – Hormone preparations are associated with an increase in lumbar spine bone mineral density (BMD) in postmenopausal women, according to a study published online May 2 in...
FDA Approves Bijuva (estradiol and progesterone) Capsules for the Treatment of Moderate to Severe Vasomotor Symptoms Due to Menopause
BOCA RATON, Fla.--(BUSINESS WIRE)--Oct. 29, 2018-- TherapeuticsMD, Inc, an innovative women’s healthcare company, today announced that the United States Food and Drug Administration (FDA) has a...
TherapeuticsMD Announces FDA Approval of Imvexxy (estradiol vaginal inserts) for the Treatment of Dyspareunia Due to Menopause
BOCA RATON, Fla., May 30, 2018 /PRNewswire/ – TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women's healthcare company, today announced that the United States Food and Drug Administration (FDA)...
FDA Approves Intrarosa (prasterone) for Postmenopausal Women Experiencing Dyspareunia
November 17, 2016 – The U.S. Food and Drug Administration approved Intrarosa (prasterone) to treat women experiencing moderate to severe pain during sexual intercourse (dyspareunia), a symptom of...
FDA Approves Brisdelle - First Non-Hormonal Treatment for Hot Flashes Associated with Menopause
June 28, 2013 --The U.S. Food and Drug Administration today approved Brisdelle (paroxetine) to treat moderate to severe hot flashes (vasomotor symptoms) associated with menopause. Brisdelle, which...
FDA Approves 10 mcg Dose of Vagifem for the Treatment of Atrophic Vaginitis Due to Menopause
PRINCETON, N.J., Dec. 2 /PRNewswire-FirstCall/ – Novo Nordisk said today that the U.S. Food and Drug Administration (FDA) has approved a 10 mcg dose formulation of Vagifem (estradiol vaginal...
FDA Medwatch Alert: Compounded Menopause Hormone Therapy Drugs
[Posted 01/10/2008] FDA informed healthcare professionals and patients that the Agency sent letters warning seven pharmacy operations that the claims they make about the safety and effectiveness of...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Postmenopausal Symptoms, Hot Flashes